Speech-Language Pathologist – One Day per week in Endicott, NY
Description
Speech-Language Pathologist- Endicott, NY | 1 Day Per Week | $80–$90/hr
The IMA Group is seeking a Speech-Language Pathologist to provide speech and language assessments in support of disability evaluation services. This part-time opportunity is ideal for clinicians who enjoy diagnostic and evaluative work without the demands of ongoing therapy, treatment planning, or caseload management.
Key Responsibilities:
- Perform speech and language evaluations
- Review developmental, educational, and medical records
- Document findings and complete structured assessment reports
- Provide objective clinical observations and recommendations
Qualifications:
- Master's degree in Speech-Language Pathology
- Active New York SLP license or ability to obtain licensure
- Experience working with pediatric populations preferred
- Strong assessment, documentation, and communication skills
Why Consider This Role:
- One consistent day per week
- Assessment-focused responsibilities
- No therapy sessions, IEP meetings, or long-term treatment plans
- Competitive hourly compensation
- Streamlined processes and administrative support
- Excellent supplemental opportunity for school-based, outpatient, or private practice SLPs
If you're looking for a flexible way to utilize your clinical expertise while maintaining control of your schedule, we'd love to hear from you.
The IMA Group is an Affirmative Action/Equal Opportunity Employer.
Our Government Services Division supports local, state, and federal agencies and delivers professional and objective medical and psychological examinations as well as ancillary services. Our Payer Services Division meets the evaluation and screening needs of Carriers, TPAs, Public Entities and Employers and includes behavioral health and physical medicine specialty services, working with a wide range of organizations within the workers' compensation, disability, liability, and auto markets. Our Clinical Research Division performs all types of Phase II-IV clinical trials in multiple therapeutic areas through a flexible nationwide network of site locations and virtual capabilities.
#LI-EG1 #LI-ONSITE